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Purpose: (i) To evaluate the biologic properties of a bi-layered 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride-cross-linked collagen membrane (CCM) in vitro. (ii) To assess the efficacy of CCM for localized bone 
regeneration in vivo.
Materials and Methods: Biodegradation of CCM compared to a native collagen membrane (NCM) was assessed 
in vitro. In vivo, twelve male New Zealand White rabbits were used. Four calvarial, circular defects (diameter 8 
mm) were created in each animal. The sites were randomly allocated to i) CCM+biphasic calcium phosphate (BCP) 
(CCM-BCP group), ii) CCM alone (CCM), iii) BCP alone (BCP) and, iv) negative control (control). Animals were sac-
rificed at 2 (n=6) and 8 weeks (n=6). Outcome measures included: micro-computed tomography (μCT) analysis (total 
augmented volume [TAV], new bone volume) and histomorphometry (total augmented area [TAA], newly formed 
bone, remaining membrane thickness [RMT]).
Result: CCM was more resistant to degradation than NCM. μCT analysis showed CCM-BCP (196.43±25.30 mm3) 
and BCP (206.23±39.13 mm3) groups had significantly (P<0.01) larger TAV than the control (149.72±12.28 mm3) after 
8 weeks. Histomorphometrically, CCM-BCP group (17.75±5.97 mm2) had significantly (P<0.01) greater TAA com-
pared to the CCM group (7.74±2.25 mm2) and the control (8.13±1.81 mm2) after 8 weeks. After 8 weeks, RMT was 
reduced by 67%. 
Conclusion: CCM can be a favorable choice of barrier membrane when performing guided bone regeneration (GBR) 
in localized bone defects. CCM has better resistance to degradation than the natural collagen membrane, in vitro. In 
vivo, CCM provides an advantageous integration of prolonged barrier function and biocompatibility for GBR.
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Introduction
Guided bone regeneration (GBR) is a widely per-
formed surgical procedure in the dental clinic to 
obtain adequate volume of alveolar ridge for im-
plant placement1). The biologic principle of GBR is 
to place a barrier membrane over an osseous defect, 
in order to exclude the overlying epithelium and 
connective tissues, and to create a secluded space for 
bone formation2-4). Therefore, it is vital for a barrier 
membrane to have suitable biological and structural 
characteristics, such as good biocompatibility, cell-
occlusiveness, space maintenance, tissue integration 
and ease of handling. 
Numerous materials for the barrier membrane 
have been introduced in the past. It has been shown 
clinically, that resorbable collagen membranes can 
produce stable long-term results in regards to the 
regenerated bone5-7). However, due to a lack of stiff-
ness, resorbable membranes need to be combined 
with a membrane-supporting (bone substitute) 
material to maintain the defect space8). A rapid and 
sometimes unpredictable degradation rate is consid-
ered a further drawback of these membranes. This 
may result in an early loss of the barrier function 
prior to complete defect healing.
In order to prolong the barrier function, collagen 
membranes have been applied pre-clinically and 
clinically, in the cross-linked form9), or in double 
layers10-12). A previous study demonstrated good bio-
compatibility and enhanced regeneration of calvarial 
defects for a chemically cross-linked collagen mem-
brane (CCM)13). Recently, this barrier membrane was 
modified into a bi-layer form consisting of a dense, 
non-porous collagen film layer facing the connective 
tissues, and a porous collagen sponge layer facing 
the defect. It is considered that this new structure 
will result in enhanced bone regeneration by im-
proving cell-occlusivity and extending the barrier 
function.
The aim of the present study was (i) to character-
ize and evaluate the biocompatibility and degrada-
tion of CCM in vitro, and (ii) to assess the efficacy of 
CCM for localized bone regeneration in vivo. 
Materials and Methods
1. Materials
1) Bilayered Cross-linked Collagen Membrane 
The bilayered chemically cross-linked type-I col-
lagen membrane (CCM) (Dalim Tissen Co., Ltd., 
Seoul, Korea) is derived from porcine skin and is 
composed of type I collagen. The membrane fea-
tures two layers: a compact non-porous film layer 
designed to prevent infiltration of soft connective 
tissue cells into the membrane-protected space; and 
(ii) a porous sponge layer, facing the bone defect and 
consisting of loosely arranged collagen fibers. The 
porous layer is intended to stabilize the blood clot 
and to enhance bone formation. 
2) Native Collagen Membrane 
The native collagen membrane (NCM) (Bio-Gide; 
Geistlich Biomaterials, Wolhusen, Switzerland) is de-
rived from porcine dermis and is composed of type 
I and III collagen. The membrane has two layers and 
been characterized in numerous studies11).
3) Synthetic Bone Substitute
The biphasic calcium phosphate (BCP, OsteonTM III; 
Genoss, Seoul, Korea) consists of 60% hydroxyapa-
tite and 40% β-tricalcium phosphate (TCP). The bone 
graft particles were 0.5~1.0 mm in size with intercon-
nected macro and micro pores. 
2. Experiments
1) In Vitro
(1) Scanning electron microscopy (SEM) observa-
tions: The morphology of CCM was observed by 
SEM (S-3000N; Hitachi, Tokyo, Japan) at an accelerat-
ing voltage of 30 kV. The thicknesses of non-porous 
and porous layers as well as the pore size were mea-
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sured on the cross-sectional view of a representative 
sample using computer software (Image-Pro Plus; 
Media Cybernetics, Rockville, MD, USA).
(2) Tensile strength test: Dry samples of CCM and 
NCM of 30×5 mm in size were compared for tensile 
strength. The membranes were placed on a universal 
tensile machine and stretched at 10 mm/min until 
the point of breakage. The ultimate strength at the 
point of breakage was recorded three times (n=3), 
from which an average was deduced.
(3) Enzymatic degradation assay: In vitro degrada-
tion test was performed using bacterial collagenase 
from Clostridium histolyticum (Sigma-Aldrich, St. 
Louis, MO, USA, Type I, 0.5~5.0 units/mg, 85.3 
unit/ml). Collagenase was dissolved in 50 mM TES 
buffer (50 mM Tris, 5 mM ethylene-diamine-tetraace-
tic acid, 2.5% sucrose) with 0.36 mM CaCl2, pH 7.4. 
Samples of CCM and NCM were weighed to obtain 
an initial dry weight (Wi) and immersed in 5 ml TES 
buffer containing 0.1 mg of collagenase for 4 hours 
at 37°C. The remaining samples were collected, 
lyophilized, and weighed to obtain the dry weight 
after enzymatic degradation (Wd). The proportion 
of the remaining weight of the samples was defined 
as: remaining weight (%)=Wd/Wi×100. The test was 
performed three times (n=3) from which an average 
was deduced.
(4) Cytotoxicity test: CCM, positive (latex film) 
and negative (polyethylene film) controls were ex-
tracted in 0.9% sodium chloride at 37°C for 72 hours. 
L-929, a mouse fibroblast cell line, was cultured for 
48 hours in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum and 1% 
antibiotic-antimycotic solution at 37°C in a 5% CO2 
humidified incubator. The extracts were used to 
replace the maintenance medium of the cell culture. 
All cultures were incubated for 24 hours, under the 
same growth condition as described above. After the 
incubation, each culture was stained with tetrazoli-
um dye solution and lysed with dimethyl sulfoxide. 
Absorbance was measured at 570 nm with an auto-
matic microplate reader. The relative cell viability 
was expressed as the percentage of the optical densi-
ties in the test medium to the fresh medium. The test 
was performed six times, from which an average 
was deduced.
2) In Vivo
(1) Animals: Twelve male New Zealand White rab-
bits weighing 2.8~3.2 kg and aged 16~20 weeks were 
used in this study. The sample size was determined 
from a previous study using the same experimental 
model13). The animals were housed in separate cages 
under standard laboratory conditions with ad libi-
tum access to water and a standard laboratory pellet 
diet. Animal selection and care, surgical protocol, 
and preparation followed routines approved by the 
Institutional Animal Care and Use Committee (Yon-
sei Medical Center, Seoul, Korea; approval number 
2015-0072). The ARRIVE (Animal Research: Report-
ing of In Vivo Experiments) guidelines were referred 
to for the design and implementation of this study14).
(2) Surgical procedures (Fig. 1): The surgical pro-
cedures were decribed in detail in a previous pub-
lication15). Briefly, an incision was made along the 
midline of the cranium from the frontal bone to the 
occipital bone in order to expose the calvarium. A 
full-thickness flap was elevated. Under copious sa-
line irrigation, four standardized round defects, each 
8 mm in diameter, were created using a trephine bur. 
The resected bone windows were removed carefully 
to avoid injury to the underlying dura mater and 
brain tissue. The defects were randomly assigned to 
the following four treatment modalities:
・CCM-BCP: cross-linked collagen membrane plus 
biphasic calcium phosphate
・CCM: cross-linked collagen membrane plus 
blood clot 
・BCP group: biphasic calcium phosphate only
・Control group: filled with blood clot only
In group CCM-BCP, the BCP particles were placed 
into the defect, then the CCM covered the entire 
15
Jin-Young Park et al: Characterization of a Bilayer Collagen Membrane
J Korean Dent Sci 2021;14(1):12-25
site. In group CCM, blood was allowed to coagulate 
inside the defect, which was covered by the CCM. 
In group BCP, only the BCP particles were packed 
into the defect. In control, only the blood clot occu-
pied the defect. For the groups containing BCP, the 
amount of BCP was standardized at 0.07~0.08 g to 
completely fill each defect by application of gentle 
pressure with a surgical instrument. For the groups 
covered by CCM, the membrane was cut to the size 
of 10×10 mm to cover the entire perimeter of defect. 
Subsequently, the flaps were repositioned and su-
tured. The sutures were removed one week postop-
eratively. The animals were euthanized at 2 weeks 
(n=6) or 8 weeks (n=6) and specimens harvested.
3. Outcome Measures
1) Micro-computed Tomography Analysis
All harvested specimens were fixed in 10% forma-
lin for 10 days and scanned with a micro-computed 
tomography (μCT) system (Sky-Scan 1173; SkyScan, 
Aartselaar, Belgium) at a resolution of 13.85 μm (130 
kV, 60 μA). The scanned data set was processed in 
DICOM (Digital Imaging and Communications in 
Medicine) format, and the area of interest was re-
constructed with On-Demand 3-dimensional (3D) 
software (Cybermed, Seoul, Korea). The overall 
dimensional topography of the calvaria and the 
grafted sites were visualized in 3D reconstructed 
images. The ROIMC for the total augmented volume 
(TAV) was defined by the outline of the circular 
defect margin, laterally; connective tissue border, su-
periorly; and the dura mater, inferiorly. For detailed 
analysis of augmented volume, all sectioned images 
were processed with NRecon 1.6.9.8 reconstruction 
software (SkyScan). 2,240×2,240 pixel images were 
acquired for creation of cross-sections and analysis 
of bone formation. Radiopaque areas were distin-
guished from the total augmented area (TAA) ac-
cording to specific 8-bit threshold grayscale values. 
The gray-scale values were set from 120 to 255 for 
bone substitute and 72 to 120 for newly formed bone. 
Areas with grayscale values lower than 72 were con-
sidered as fibrovascular tissue. Within the ROIMC, the 
following parameters were measured:
・TAV (mm3): entire augmented volume.
・ New bone volume (NBV, mm3): volumetric mea-
surement of the newly formed bone within the 
defect.
・ Remaining material volume (RMV, mm3): volu-
metric measurement of the remaining graft par-
ticles.
2) Histologic and Histomorphometric Analysis
The fixed specimens were decalcified in 5% formic 
A B
Fig. 1. Experimental design in the rabbit calvarium. (A) Four circular defects 8 mm in diameter were prepared using trephine bur. (B) 
Each defect was assigned to an experimental group. Clockwise from top left; negative control, BCP, CCM-BCP, and CCM. BCP: bipha-
sic calcium phosphate, CCM: cross-linked collagen membrane.
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acid for 14 days and then embedded in paraffin. Se-
rial 5 μm thick sections were cut through the central 
portion of each experimental site. Only sections lo-
cated at the middle of the defects were selected, and 
stained with hematoxylin and eosin and Masson 
trichrome. The histologic slides were observed and 
digitally captured under a light microscope (DM LB; 
Leica Microsystems, Wetzlar, Germany) equipped 
with a camera (BX50; Olympus, Tokyo, Japan). After 
the conventional microscopic examination assess-
ing the various tissues (bone, bone substitute mate-
rial, non-mineralized tissue, membrane), computer-
assisted histometric measurements in the calvarial 
defect were performed using an automated image 
analysis system (Image-Pro Plus; Media Cybernet-
ics). The ROIH was defined by the margins of the 
original bone, laterally; the periosteum or the CCM, 
superiorly; and the dura mater, inferiorly. The fol-
lowing parameters were measured within the ROIH:
・TAA: This consists of the sum of the area of new 
bone, residual particles, fibrovascular tissues 
within the ROIH.
・New bone area (NBA): Area of newly formed 
bone within the ROIH.
・Residual particle area (RPA): Area of the remain-
ing bone graft particles within the ROIH.
・Remaining membrane height (RMH): Height of 
the CCM measured at 3 different points of the 
defect; left, middle and right.
4. Statistical Analysis
The statistical analysis was performed using a com-
mercially available software program (IBM SPSS Sta-
tistics ver. 23; IBM Corp., Armonk, NY, USA). μCT 
measurements and histomorphometric records were 
summarized in terms of the mean and standard 
deviation (SD) values. The relationship between the 
measured parameters and each of the factors was 
examined using the Kruskal–Wallis test (for factors 
with more than two levels) and Mann–Whitney U-
test (for factors with two levels). Wilcoxon Rank test 
was used to compare the same experimental group 
between the two time periods (2 and 8 weeks). Statis-
tical significance was considered when P<0.05.
Result
1. In Vitro
1) SEM Imaging (Fig. 2)
The thickness of CCM was measured at 350 μm, 
the dense non-porous layer was 25 μm, and the 
spongy porous layer was 325 μm. The pore size of 
the spongy layer was approximately 20 μm. Thin 
sheets of collagen structures were arranged in a lat-
tice shape to form the porous layer of CCM. The 
dense portion had a smooth surface with no pores. 
A B C
Fig. 2. SEM images of the bilayer EDC-cross-linked type-I collagen membrane (CCM) (×100 magnification). (A) Cross-sectional view 
of the CCM showing the porous sponge layer (left) and the dense film layer (right) (Scale bar=300 μm). (B) The surface of the porous 
layer (Scale bar=300 μm). (C) The smooth surface of dense film layer showing no pores (Scale bar=300 μm). SEM: scanning electron 
microscopy, EDC: 1-ethyl-3-(3-dimethylaminopropyl).
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The surface of the dense film layer appeared smooth 
even at a very high magnification (×1,000).
2) Tensile Strength Test
The results showed that the CCM (5.22±0.1 N/mm2; 
mean±SD) and NCM (5.1±0.1 N/mm2) had similar 
mechanical strengths.
3) Enzymatic Degradation Assay
After 4 hours of degradation by bacterial col-
lagenase, the remaining sample weight of CCM 
(43.09±0.05%) was significantly greater than that of 
NCM (13.46±0.08%).
4) Cytotoxicity Test
The relative cell viability was comparable between 
CCM (99.74±2.7%) and the negative control (poly-
ethylene, 100±2.1%). These values were significantly 
greater than that of the positive control (latex, 
2.15±0.38%).
Table 1. Results from the micro-computed tomography analysis 
Study group TAV NBV RMV
2 weeks
  CCM-BCP 222.32±80.41 34.37±11.04a,b 17.77±3.41
  CCM 186.55±66.9 13.80±9.79
  BCP 186.33±38.32 26.91±5.71a 15.06±3.29
  Control 151.68±29.91 6.7±6.46
8 weeks
  CCM-BCP 196.43±25.30a 38.43±7.22 17.38±6.42
  CCM 166.02±30.38 23.73±5.4
  BCP 206.23±39.13a 34.61±13.96 13.63±5.06
  Control 149.72±12.28 22.83±10.56
TAV: total augmented volume, NBV: new bone volume, RMV: remaining material volume, CCM: cross-linked collagen membrane, 
BCP: biphasic calcium phosphate.
Values are presented as mean±standard deviation.
aStatistically significant difference compared to the control group. bStatistically significant difference compared to the CCM group.
A B
Fig. 3. Three-dimensional reconstructed radiographic views of the defects after 2 weeks (A), and 8 weeks of healing (B). Scattering of 
the BCP particles can be observed in the BCP group, whereas BCP is contained within the defect in the CCM-BCP group. BCP: bipha-
sic calcium phosphate, CCM: cross-linked collagen membrane.
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2. In Vivo Experiment 
Although 3 of the animals had slight tearing of the 
dura mater during surgery, postoperative complica-
tions such as swelling and bleeding were at low lev-
els and no signs of infection or abnormal appearanc-
es could be detected. All animals remained healthy 
throughout the entire experimental period. Wound 
healing was uneventful.
1) μCT Analysis
The results of the μCT analysis are summarized in 
Table 1. In the 3D reconstructed view, BCP particles 
were well-contained by the CCM in the CCM-BCP 
group, whereas in the BCP group, scattering of the 
BCP particles was frequently seen (Fig. 3). Cross-
sectional view of each group at both time points are 
represented in Fig. 4.
At 2 weeks, the CCM-BCP group showed the high-
est TAV (222.32±80.41 mm2), but there was no sig-
nificant difference compared to controls (P=0.369). 
The CCM-BCP group (34.37±11.04 mm3) also dem-
onstrated the highest NBV when compared to the 
control (6.7±6.46 mm3; P=0.000) and the CCM group 
(13.80±9.79 mm3, P=0.004). NBV was significantly 
greater (P=0.006) in the BCP group (26.91±5.71 mm3) 
than in the control group (6.7±6.46 mm3).
At 8 weeks, CCM-BCP and BCP groups had 
significantly higher TAV than the control group. 
However, in terms of the NBV, there was no signifi-
cant difference between the four groups. The RMV 
showed a slight decrease from 2 weeks (CCM-BCP 
group, 17.77±3.41 mm3; BCP group, 15.06±3.29 mm3) 
to 8 weeks (CCM-BCP group, 17.38±6.42 mm3; BCP 
group, 13.63±5.06 mm3). 
2) Descriptive Histology
(1) CCM-BCP group: At 2 weeks, the defect spaces 
were well-augmented and BCP particles well-
contained below the CCM membrane (Fig. 5A). The 
CCM maintained an unfragmented barrier. Callus-
like woven bone was found in abundance, and start-
ed to proliferate from the periphery of the defects. At 
8 weeks, although all defects were not completely re-
paired, woven bone was replaced by dense lamellar 
bone. Lamellar bone had a tendency to form clusters 




















Fig. 4. Color coded cross-sectional radiographic view of the defects at 2 and 8 weeks. Bone is shown in purple, bone substitute parti-
cles are shown in yellow-blue. New bone formation occurred mainly at the defect periphery in the control group. The original volume 
of the cranial bone before defect preparation is maintained with CCM-BCP and BCP groups. BCP: biphasic calcium phosphate, CCM: 
cross-linked collagen membrane.
19
Jin-Young Park et al: Characterization of a Bilayer Collagen Membrane
J Korean Dent Sci 2021;14(1):12-25
tramembranous neo-ossification was seen in most of 
the specimens. In one of the specimens in particular, 
the porous layer of CCM was completely replaced 
by a sheet of mature lamellar bone, and covered the 
cranial part of the defect (Fig. 6A).
(2) CCM group: At 2 weeks, membranes main-
tained the original thickness and shape (Fig. 5B). 
The dense film layer could be distinguished from 
the porous sponge layer (Fig. 7). Newly formed 
bone was found extending from the native bone. At 
8 weeks, in the majority of the specimens, almost 
complete closure of defect was seen (Fig. 6B). In gen-
eral, the porous layer was mostly resorbed, whereas 
the dense layer remained. In two of the specimens, 
formation of blood vessels could be seen within the 
dense collagen film layer (Fig. 7).
(3) BCP group: At 2 weeks, direct apposition of new 
bone onto the porous structure of the BCP particles 
could be observed (Fig. 5C). At 8 weeks, new bone 
formation seemed to occur in small clusters around 
BCP particles as focal points, rather than forming a 
continuous layer from the periphery (Fig. 6C). Less 
particles occupied the defect compared to the CCM-
BCP group.
(4) Control: At 2 weeks, minimal new bone forma-
tion was observed (Fig. 5D). In general, the defect 
spaces were filled with underlying brain tissues. At 8 









Fig. 5. Histological images obtained at 2 weeks. (A-D) Low magnification views of the groups CCM-BCP, CCM, BCP, and control, re-
spectively (Masson Trichrom, bar=1 mm). (E-H) High magnified views of each highlighted area (H&E, bar=500 μm). (E) CCM appears 
to maintain the original shape. (F) The porous layer is integrated and adapted to the defect margin without any adverse reactions. (G) 
The pores of the BCP are beginning to fill with woven bone structures. (H) Woven bone formation in island produced by the overly-
ing periosteum. The defect margins are labeled with arrowheads. BCP: biphasic calcium phosphate, CCM: cross-linked collagen mem-
brane, DL: dense layer, PL: porous layer, NB: new bone.
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riphery reached further into the center of the defect. 
In part lamellar bone formation was observed (Fig. 
6D).
3) Histomorphometrical Analysis
The results of the micro histomorphometrical analy-
sis are summarized in Table 2. At 2 weeks, the CCM-
BCP group had the highest TAA (15.78±4.63 mm2), 
when compared to the control (8.13±1.81 mm2) and 
the CCM group (7.74±2.25 mm2) (P=0.009, 0.002 re-
spectively). CCM group also showed significantly 
higher TAA compared to the control group (P=0.009).
At 8 weeks, CCM-BCP group (17.75±5.97 mm2) 
had a significantly higher TAA compared to the 
CCM (9.23±2.91 mm2) and control groups (3.7± 
0.76 mm2) (P=0.004, 0.004), but not to the BCP 
group (13.93±2.29 mm2) (P=0.792).









Fig. 6. Histological images obtained at 8 weeks. (A-D) Low magnification views of the groups CCM-BCP, CCM, BCP, and control, re-
spectively (Masson Trichrome, bar=1 mm). (E-H) High magnified views of each highlighted area (H&E, bar=500 μm). (E) The dense 
layer is remaining after 8 weeks, whereas the porous layer has been replaced by a sheet of new bone. (F) Porous layer shows inte-
gration with connective tissue matrix that can be expected to turn into bone tissue after a longer healing period. The dense layer 
remains unresorbed and provides protection over the top. (G) BCP particles at the top middle aspect of the defect are surrounded 
by newly formed bone, which displays good osteoconductivity of the bone substitute material. (H) Bony islands in the control group 
without much defect closure. The defect margins are labeled with arrowheads. BCP: biphasic calcium phosphate, CCM: cross-linked 
collagen membrane, DL: dense layer, PL: porous layer, NB: new bone.
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(NBA) revealed significantly higher values for CCM-
BCP (2.15±0.99 mm2) and CCM (2.43±0.29 mm2) 
compared to the control group (1.12±1.92 mm2) 
(P=0.004, 0.03 respectively) at 2 weeks.
The height of the membranes (RMH) in the CCM-
BCP and CCM groups decreased between 2 weeks 
(0.28±0.55 mm) and 8 weeks (0.18±0.12 mm). 
Discussion
This study revealed that the combined use of a 
membrane and bone substitute particles (CCM-BCP) 
resulted in the highest TAA based on histomor-
phometry. In vitro, CCM demonstrated a signifi-
cantly higher resistance to degradation compared to 
a NCM. In vivo data, indicated that the membrane 
underwent degradation process predominantly of 
the spongeous layer and the dense layer remained 
up to 8 weeks. 
The CCM-BCP group in this study showed the 
greatest augmented area, although the difference 
between the CCM-BCP and BCP groups did not 
reach a statistical significance. Nonetheless, μCT 
images showed that there was less scattering of the 
bone substitute particles in the CCM-BCP group 
compared to BCP group. These results indicate that 
bone substitute is needed to gain graft volume, and 
CCM may help to stabilize the graft by preventing 
scattering of the particles. It is well known that hy-
drated collagen membrane lacks structural rigidity, 
therefore, bone substitute material is required to 
support the membrane16). In a systematic review, the 
combined approach of a particulated bone substitute 
Table 2. Results from the histomorphometric analysis
Study group TAA NBA RPA RMH
2 weeks
  CCM-BCP 15.78±4.63a,b 2.15±0.99 3.44±0.88 0.58±0.28
  CCM 9.23±2.91a 2.69±2.07 0.52±0.21
  BCP 13.93±2.29a 1.27±0.58 3.52±0.5
  Control 3.7±0.76 1.12±1.92
8 weeks
  CCM-BCP 17.75±5.97a,b 3.79±2.62 3.49±0.85 0.14±0.13c
  CCM 7.74±2.25 2.43±0.29 0.17±0.13c
  BCP 15.09±2.44a 3.92±1.25 3.44±0.68
  Control 8.13±1.81 2.76±1.28
TAA: total augmented area, NBV: new bone volume, RPA: residual particle area, RMH: remaining membrane height, CCM: cross-linked 
collagen membrane, BCP: biphasic calcium phosphate.
Values are presented as mean±standard deviation.
aStatistically significant difference compared to the control group. bStatistically significant difference compared to the CCM group. 
cStatistically significant difference compared to the corresponding groups at 2 weeks.
Fig. 7. High magnification view of the cross-linked collagen 
membrane after 8 weeks, showing the dense layer (DL) and the 
porous layer (PL). Penetration of blood vessels (arrowheads) can 
be seen within the membrane (Masson Trichrome, bar=100 μm).
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and collagen membrane was the most widely used 
method for GBR in localized bone defects17). A study 
in the rat calvarial defect model utilized different 
combinations of NCM, deproteinized bovine bone 
mineral (DBBM), and enamel matrix derivative18) for 
GBR. The results after 4 months revealed that the 
presence of barrier membrane increased the rate of 
complete defect closure, however, the regenerated 
bone had a concave appearance due to membrane 
collapse. The use of DBBM resulted in increased 
thickness of calvaria but DBBM particles were con-
sistently encapsulated by loose fibrous tissue even 
when membrane was used. Likewise, in the current 
study, the use of BCP did not result in significant in-
crease in NBA/NBV after 8 weeks, which confirms 
that its role is confined to support and provision of 
space under membrane. Furthermore, the use of a 
membrane only (CCM group) was not able to main-
tain space, and the TAV was significantly less com-
pared to the bone grafted groups (BCP, CCM-BCP 
groups). When interpreting this result, it should be 
noted that the membrane was placed only over the 
top of the defect, which cannot prevent the underly-
ing brain tissue from invading the defect space.
Sustained barrier function for up to 6 months3,4,12,19) 
and space maintenance18) are reported to be key ele-
ments for successful GBR. This study revealed that 
CCM was more resistant to degradation than a NCM 
in vitro. The CCM in this study was chemically 
crosslinked using 1-ethyl-3-(3-dimethylaminopropyl 
(EDC) carbodiimide. Previous studies have also 
shown that EDC-CCM possesses great resistance to 
enzymatic digestion. Furthermore, the byproducts 
of degradation had low cytotoxicity compared to the 
conventional chemical agents such as glutaraldehyde 
or polypeptides, indicating potential expediency as 
a scaffold in tissue engineering13,20) In vivo, the dense 
film layer of CCM remained intact up to 8 weeks, 
whereas the porous sponge layer was substituted 
by newly formed bone or dense collagenous tissue. 
Similar attempts have been made previously to im-
prove the bio-durability of collagen membranes. A 
study in the rabbit calvaria also applied a porcine-
derived NCM in a double layer for onlay graft10). 
They reported that a single layer disappeared com-
pletely after 4 months, whereas a double layer sus-
tained barrier function after 6 months and produced 
better bone mineralization density. In another study 
in rat calvarial defect model, NCM was also applied 
in double layers11). They found remaining collagen 
area was greater in the double layer than the single 
layer. The NCM itself is a bi-layered membrane con-
sisting of a compact layer and a porous layer, which 
are designed to serve the same purposes as the CCM 
in this study. Considering that a single layer of NCM 
underwent 30% reduction in thickness over a 5 week 
period (between 4 and 9 weeks), CCM might be 
more susceptible to degradation in vivo (67% reduc-
tion in thickness between 2 and 8 weeks). Neverthe-
less, only the porous sponge layer of CCM appeared 
to undergo biodegradation, whereas the dense film 
layer remained intact. The slow degradation of the 
dense layer appears to be accompanied by limited 
tissue integration, and is observed by the split sepa-
rating the membrane from adjacent connective tis-
sue. This separation could have been enhanced as a 
result of histologic processing and weak attachment 
of the connective tissue to the surface. The dense film 
layer may be speculated to retain its cell-occlusivity, 
as it appears to maintain the continuous outline his-
tologically. 
Although the bone filler in this study was able to 
maintain the graft volume after 8 weeks, there has 
not been a significant increase in new bone. This 
could be explained by the slow rate of graft degra-
dation and large amount of residual particles still 
occupying the defect after 8 weeks. β-TCP is known 
to undergo fast resorption and replacement by new 
bone, whereas HA is more resilient and provides 
osteoconductivity. The HA:β-TCP ratio of 60:40 was 
utilized in this study, and the rate of degradation 
was comparable to the reports of other studies15,21,22). 
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Materials with slow degradation rate can be more 
suitable for challenging defect sites that takes longer 
time to regenerate, for example, onlay grafts and 
vertical augmentation. However, in self-containing 
defects such as the present study, a greater β-TCP 
content may be preferred. 
Biocompatibility of the crosslinked collagen mem-
brane has been a cause for concern in the recent 
literature. Certain crosslinking agents such as glu-
taraldehyde are known to evoke tissue reaction as a 
byproduct of enzymatic degradation23,24). A previous 
clinical trial demonstrated more frequent incidence 
of membrane exposure with CCM25), and transmem-
braneous angiogenesis, which is supposedly benefi-
cial for osteogenesis, was prevented until 24-weeks 
in an enzymatically cross-linked membrane26). In ad-
dition, an increase in the degree of cross-linking was 
inversely related to tissue integration in a study in 
rats27). The collagen membrane in the present study 
was chemically cross-linked using EDC, which has 
been shown to be safe to use in vitro20,28) and in ani-
mal studies13). In contrast to other chemical agents 
such as glutaraldehyde or polypeptide, EDC does 
not remain as a part of the cross-linkage after deg-
radation but simply change to water-soluble urea 
derivatives that have very low cytotoxicity20). In 
vitro analysis of the present study showed high cel-
lular compatibility, and no complications in terms of 
membrane exposure and abnormal tissue reaction 
were observed in vivo. Transmembraneous angio-
genesis, which has been reported to be hindered in 
CCM, showed to take place at 8 weeks in the dense 
film layer of the CCM. Furthermore, it is noteworthy 
that in the 8-week specimens, intra-membrane neo-
ossification could be observed in the porous layer of 
the CCM. In one of the specimens, the porous layer 
was nearly completely replaced by a sheet of new 
bone, which suggests that the current membrane 
has excellent tissue integration and biocompatibility. 
These results propose that the EDC-CCM has the po-
tential for enhanced performance with a better struc-
tural design than the current one. An interesting sug-
gestion in a study using NCM11) was that the main 
pattern of resorption was internal and not external, 
which can be related to the transmembraneous an-
giogenesis of NCM26). A second layer of CCM on top 
of NCM may compensate for the disadvantage of 
each membrane, while enhancing the longevity of 
barrier function.
There are some limitations to this study. Firstly, 
there was no in vivo comparison between CCM and 
NCM, although the two materials were compared 
in vitro. This was not feasible because the rabbit 
calvarium can only accommodate for 8 mm circular 
defects. Introducing NCM and NCM-BCP groups 
would result in elimination of BCP and empty con-
trol groups, and these control groups were necessary 
to fulfill the initial purpose of this study. Secondly, 
the sample size was too small to reach rigid statisti-
cal power. The sample size of the current study was 
based on previous experiments carried out on the 
same experimental model. However, sample size 
calculations based on the results from this study 
revealed that ideally, 30 animals should be used to 
reach a statistical value. Thirdly, in the CCM group, 
the membrane was applied over the top of the de-
fect, but the brain tissue below often bulged into the 
defect space, especially if the dura mater was torn 
during preparation of defect. Therefore, ideally, the 
membrane should be placed on both sides of the de-
fect to properly assess the space maintaining ability.
Conclusion
CCM can provide a favorable choice of barrier 
membrane when performing GBR in localized bone 
defects. CCM has better resistance to degradation 
than natural collagen membrane, in vitro. In vivo, 
CCM provides advantageous integration of barrier 
function and biocompatibility for GBR.
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